Categories

Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business

Popular Articles

Ring-ring bling
These phones and laptops will make you look like a million bucks.

NTPC plans 100 Mw solar projects in Gujarat
Powering its way ahead in tapping renewable energy sources for power generation, public sector power utility NTPC (formerly National Thermal Power Corporation) has set the ball rolling for its two solar thermal units of 50 Mw each in Gujarat. The company has firmed up its plans to initially install a solar power generation capacity of 100 Mw in the state, which may go up to 300 Mw at a later stage.

News of the day

CRR hike slightly aggressive, int rates not seen rising now
Economists were "slightly surprised" by the extent of hike (75 basis points) in mandatory cash reserves of banks held by the Reserve Bank, but felt that the apex bank"s move was strongly influenced by rising inflationary pressures.
Small Business

Cadila Pharma eyes Rs 80 crore from Risorine

Aims to enter China, Russia and African countries - Cadila-Novavax JV can produce 250 mn doses of H1N1 vaccine - Cadila Pharma-Novavax JV to produce swine flu vaccine - Cadila expects Rs 100-cr revenue from Policap - Cadila looking at global tie-ups for Polycap - Cadila Pharma to launch product to curb sudden cardiac death Ahmedabad-based pharma major Cadila Pharmaceuticals is betting big on the latest product from its stable, Risorine, a combination drug for treating tuberculosis, as it plans to take the drug to markets like China, Russia and African countries in the long run and also expects to multiply its turnover from the segment by over ten times in the coming two years. Speaking at the launch of the drug, I A Modi, chairman, Cadila Pharmaceuticals said that he expected the company"s revenues from the tuberculosis segment which is around Rs 6-8 crore now to touch over Rs 80 crore within the next two years. "Currently, the share of tuberculosis department of respiratory medicine at NHL Municipal Medical College at Ahmedabad, pointed out that Risorine could even replace the currently used Rifampicin used in the "Directly Observed Treatment Short-course" (DOTS) therapy. Nearly, 70-80 per cent of all tuberculosis cases in the country would receive medication under the DOTS programme run by the Central government in association with states.” "Even out of these patients, nearly 50 per cent do come to a private practitioner for advice", observed Naresh Patel, faculty and head, Tuberculosis and Respiratory Medicine, NHL, Municipal Medical College, Ahmedabad. India currently houses the maximum number of tuberculosis patients in the world, nearly 21 per cent of the world"s patient population. The country reports two deaths in every three minutes. On top of this, India has more than 25 lakh HIV positive cases and the risk of contracting tuberculosis is around five times more in these patients.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009